335
Participants
Start Date
August 31, 2012
Primary Completion Date
July 31, 2013
Study Completion Date
July 31, 2013
indacaterol
indacaterol acetate 75 µg or indacaterol acetate 150 µg delivered via Concept 1 inhaler
placebo
placebo delivered via Concept 1 inhaler
mometasone furoate
via Twisthaler inhaler
Novartis Investigative Site, Sofia
Novartis Investigative Site, Sofia
Novartis Investigative Site, Sofia
Novartis Investigative Site, Sofia
Novartis Investigative Site, Sofia
Novartis Investigative Site, Sofia
Novartis Investigative Site, Sofia
Novartis Investigative Site, Sofia
Novartis Investigative Site, Sofia
Novartis Investigative Site, Plovdiv
Novartis Investigative Site, Veliko Tarnovo
Novartis Investigative Site, Lovech
Novartis Investigative Site, Pleven
Novartis Investigative Site, Vyšné Hágy
Novartis Investigative Site, Rousse
Novartis Investigative Site, Varna
Novartis Investigative Site, Varna
Novartis Investigative Site, Lübeck
Novartis Investigative Site, Dortmund
Novartis Investigative Site, Bonn
Novartis Investigative Site, Mainz
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, Wiesbaden
Novartis Investigative Site, Wiesloch
Novartis Investigative Site, München
Novartis Investigative Site, Bad Wörishofen
Novartis Investigative Site, Brampton
Novartis Investigative Site, Downsview
Novartis Investigative Site, Etobicoke
Novartis Investigative Site, Grimsby
Novartis Investigative Site, Hamilton
Novartis Investigative Site, Newmarket
Novartis Investigative Site, Toronto
Novartis Investigative Site, Woodstock
Novartis Investigative Site, Montreal
Novartis Investigative Site, Pointe-Claire
Novartis Investigative Site, Saint Romuald
Novartis Investigative Site, Ste-Foy
Novartis Investigative Site, Dresden
Novartis Investigative Site, Fukuoka
Novartis Investigative Site, Yanagawa
Novartis Investigative Site, Gifu
Novartis Investigative Site, Obihiro
Novartis Investigative Site, Sapporo
Novartis Investigative Site, Ako-shi
Novartis Investigative Site, Himeji
Novartis Investigative Site, Naka-gun
Novartis Investigative Site, Sakaidechō
Novartis Investigative Site, Kyoto
Novartis Investigative Site, Tsu
Novartis Investigative Site, Beppu
Novartis Investigative Site, Ōita
Novartis Investigative Site, Kishiwada
Novartis Investigative Site, Chuo-ku
Novartis Investigative Site, Cyuo-ku
Novartis Investigative Site, Itabashi-ku
Novartis Investigative Site, Kiyose
Novartis Investigative Site, Setagaya-ku
Novartis Investigative Site, Machida-shi
Novartis Investigative Site, Ōta-ku
Novartis Investigative Site, Yonezawa
Novartis Investigative Site, Rotterdam
Novartis Investigative Site, Sittard-Geleen
Novartis Investigative Site, Gdansk
Novartis Investigative Site, Krakow
Novartis Investigative Site, Bialystok
Novartis Investigative Site, Bieńkówka
Novartis Investigative Site, Bydgoszcz
Novartis Investigative Site, Lodz
Novartis Investigative Site, Lodz
Novartis Investigative Site, Lublin
Novartis Investigative Site, Lublin
Novartis Investigative Site, Torun
Novartis Investigative Site, Wroclaw
Novartis Investigative Site, Żnin
Novartis Investigative Site, Banská Bystrica
Novartis Investigative Site, Bardejov
Novartis Investigative Site, Levice
Novartis Investigative Site, Košice
Novartis Investigative Site, Košice
Novartis Investigative Site, Zvolen
Novartis Investigative Site, Dunajská Streda
Novartis Investigative Site, Komárno
Novartis Investigative Site, Liptovský Hrádok
Novartis Investigative Site, Liptovský Mikuláš
Novartis Investigative Site, Nové Zámky
Novartis Investigative Site, Rimavská Sobota
Novartis Investigative Site, Spisská Nová Ves
Novartis Investigative Site, Topoľčany
Novartis Investigative Site, Wŏnju
Novartis Investigative Site, Seoul
Novartis Investigative Site, Cheongju-si
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY